- Home
- WIMI vs MIRA Comparison
WIMI vs MIRA Comparison
Compare WIMI & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIMI
- MIRA
- Stock Information
- Founded
- WIMI 2015
- MIRA 2020
- Country
- WIMI China
- MIRA United States
- Employees
- WIMI 107
- MIRA N/A
- Industry
- WIMI Computer Software: Prepackaged Software
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- WIMI Technology
- MIRA Health Care
- Exchange
- WIMI Nasdaq
- MIRA Nasdaq
- Market Cap
- WIMI 23.9M
- MIRA 19.5M
- IPO Year
- WIMI 2020
- MIRA 2023
- Fundamental
- Price
- WIMI $3.53
- MIRA $1.30
- Analyst Decision
- WIMI
- MIRA Strong Buy
- Analyst Count
- WIMI 0
- MIRA 2
- Target Price
- WIMI N/A
- MIRA $14.00
- AVG Volume (30 Days)
- WIMI 7.6M
- MIRA 2.4M
- Earning Date
- WIMI 01-01-0001
- MIRA 08-12-2025
- Dividend Yield
- WIMI N/A
- MIRA N/A
- EPS Growth
- WIMI N/A
- MIRA N/A
- EPS
- WIMI N/A
- MIRA N/A
- Revenue
- WIMI $84,137,968.00
- MIRA N/A
- Revenue This Year
- WIMI N/A
- MIRA N/A
- Revenue Next Year
- WIMI N/A
- MIRA N/A
- P/E Ratio
- WIMI N/A
- MIRA N/A
- Revenue Growth
- WIMI 19.25
- MIRA N/A
- 52 Week Low
- WIMI $0.27
- MIRA $0.57
- 52 Week High
- WIMI $2.92
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- WIMI 60.88
- MIRA 56.46
- Support Level
- WIMI $2.73
- MIRA $1.07
- Resistance Level
- WIMI $3.09
- MIRA $1.39
- Average True Range (ATR)
- WIMI 0.26
- MIRA 0.10
- MACD
- WIMI 0.15
- MIRA 0.00
- Stochastic Oscillator
- WIMI 83.58
- MIRA 70.78
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.